Funded Tech Companies
Trius Therapeutics
Wondering who provided funding to Trius Therapeutics? InterWest Partners, Prism VentureWorks and Kleiner Perkins Caufield & Byers joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
Trius Therapeutics
Company Status
Acquired or Merged
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
6310 Nancy Ridge Drive 105
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Company Background Information
Overview
Trius Therapeutics is discovering and developing innovative antibacterial drugs for thetreatment of life-threatening infections. The company's lead product candidate, TR-701 isa novel oral and IV oxazolidinone antibiotic with potent activity against Gram positivebacterial pathogens.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
8/3/2010
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jeffrey Stein
Chief Financial Officer
John Schmid
Chief Medical Officer
Philippe Prokocimer
Chief Scientific Officer
John Finn
VP - Bus. Development
Neil Abdollahian
VP - Regulatory Affairs
Karen Potts
Company Investors
- InterWest Partners (Nina Kjellson)
- Prism VentureWorks (Brendan O'Leary)
- Kleiner Perkins Caufield & Byers (Risa Stack)
- Versant Ventures (Brian Atwood)
- Prism VentureWorks (Brenan O'Leary)
- Sofinnova Ventures (Michael Powell)
- Seraphim Partners
- Tech Coast Angels (Julia Brown)
Browse more funded tech companies:
Triumvira Immunologics | Trivascular Technologies
Share this article
About Our VC Deals Database
This tech company profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs